drugset / Trial / NCT00511277
Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study
Phase 4
Completed
60 enrolled
Institute of Application-oriented Research and Clinical Trials GmbH
University of Göttingen · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is: To investigate whether a treatment with quetiapine for six months in patients with first-episode psychosis may be effective in treating depressive symptoms. To investigate whether a treatment with quetiapine for six months in patients with first-episode psychosis may be effective in mania-like symptoms and to evaluate the general efficacy in psychopathology as well as the safety and tolerability of quetiapine.
Timeline
- Start
- 2007-08
- Primary completion
- 2010-10
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 300 mg | Oral |
| Subject | Quetiapine | Small molecule | 800 mg | Oral |